Your browser doesn't support javascript.
Parents' perceptions on COVID-19 vaccination as the new routine for their children ≤ 11 years old.
Humble, Robin M; Sell, Hannah; Wilson, Sarah; Sadarangani, Manish; Bettinger, Julie A; Meyer, Samantha B; Dubé, Ève; Lemaire-Paquette, Samuel; Gagneur, Arnaud; MacDonald, Shannon E.
  • Humble RM; Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.
  • Sell H; School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
  • Wilson S; Public Health Ontario, ICES, Dalla School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Sadarangani M; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Bettinger JA; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Meyer SB; School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.
  • Dubé È; Department of Anthropology, Laval University, Québec City, Québec, Canada.
  • Lemaire-Paquette S; Centre de Recherche du CHUS, Sherbrooke, Québec, Canada.
  • Gagneur A; Département de pédiatrie, Université de Sherbrooke, Centre de Recherche du CHUS, Sherbrooke, Québec, Canada.
  • MacDonald SE; Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada; School of Public Health, University of Alberta, Edmonton, Alberta, Canada. Electronic address: smacdon@ualberta.ca.
Prev Med ; 161: 107125, 2022 08.
Article in English | MEDLINE | ID: covidwho-1921454
ABSTRACT
Canadian children 5-11 years old became eligible for COVID-19 vaccination on November 19, 2021, with eligibility for younger children expected later. We aimed to descriptively assess parents' COVID-19 vaccine intentions and acceptability of future doses, including co-administration and annual vaccination for their children. We conducted a cross-sectional Canadian online survey of parents from October 14-November 12, 2021, just prior to authorization of the pediatric formulation of the BNT162b2 COVID-19 vaccine for children aged 5-11 years. We assessed parents' intention to vaccinate their children aged 5-11 years, 2-4 years, and 6-23 months; reasons for their intention; and preferences for delivery and access to vaccines. Of 1129 parents, 56% intended to vaccinate their child aged 5-11 years against COVID-19; intentions were lower for children aged 6-23 months (41.9%) and 2-4 years (45.4%). Most parents who intended to vaccinate supported co-administration with routine (61.1%) or influenza (55.4%) vaccines, administration at school (63.6%), receipt of booster doses of COVID-19 vaccine (57.8%), and annual vaccination (56.4%) for their child. Despite parents' high COVID-19 vaccination uptake for themselves (88.8%), intentions for children aged 5-11 years was low. Currently, 56.9% of Canadian children aged 5-11 years have received one dose of a COVID-19 vaccine, and only 37.1% are fully vaccinated. Given that intentions for children <5 years was lower than those 5-11 years, we can also expect low uptake in this group. Parents' preferences regarding delivery and access to COVID-19 vaccination should be considered by public health officials when planning vaccination strategies for children.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines Limits: Child / Child, preschool / Humans Country/Region as subject: North America Language: English Journal: Prev Med Year: 2022 Document Type: Article Affiliation country: J.ypmed.2022.107125

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines Limits: Child / Child, preschool / Humans Country/Region as subject: North America Language: English Journal: Prev Med Year: 2022 Document Type: Article Affiliation country: J.ypmed.2022.107125